7^th World Congress on
Womens Health and Midwifery

Director-Professor of Obstetrics and Gynecology Shakuntala Chhabra formerly held the positions of Dean, Medical Superintendent of the hospital, and Head of the Department of Obstetrics and Gynecology at MGIMS (1984–2007). (2007-10). She is currently assisting MGIMS in building a hospital for children and mothers at Melghat's village of Utavali has the dubious reputation of having a high prevalence of severe malnutrition. She graduated from MBBS in 1970, DGO in 1973, and MD in 1975 in Nagpur's Government Medical College. In 1975, she transferred to MGIMS as a lecturer. She was appointed director of the institute's obstetrics and gynaecology department in 1984. Throughout her illustrious career, she won numerous accolades. In 2002, she served as the Association of Gynecologic Oncologists of India's president. She oversees the Community Based Reproductive Health Care Project and the Sevagram Project for the welfare of unwed mothers. She has held the position of Chief Executive Officer of Aakanksha for more than 20 years. Women's reproductive health, gynaecological oncology, and the training of medical professionals are some of her particular research interests.

Women’s reproductive health, Gynecological Oncology, and education of health professionals.

Raja Affendi Raja Ali is a professor of medicine and the current Dean of the National University of Malaysia (UKM) Medical Centre in Kuala Lumpur, Malaysia. He is also a consultant gastroenterologist at the Department of Medicine. He obtained his honours degree in medicine from the National University of Ireland, as well as numerous prizes and accolades for his academic and clinical teaching achievements. In 2017, he was elected President-elect of the Malaysian Society of Gastroenterology and Hepatology, and he has held numerous other positions, including council member of the Asia Pacific Association of Gastroenterology and Endoscopy (2018-2020), member of the Asian Organization for Crohn's and Colitis' educational committee (2018-2020), member of the Malaysian Academy of Medicine (2016), and chairman of the local organising committee for the Asia Pacific Association of Gastroenterology and Endoscopy.

Gastroenterology | Hepatology

Professor of Genome Medicine in the Department of Physiology, Norfilza Mohd Mokhtar is currently the Chairman of the Health and Advanced Medicine cluster. She was the International Program Coordinator for the Faculty of Medicine. She graduated from Universiti Sains Malaysia with a Doctor of Medicine degree. Professor Stephen Charnock Jones and Professor Stephen Smith of the Department of Obstetrics and Gynaecology, University of Cambridge, United Kingdom, mentored her in molecular biology from 2001 to 2005. From 2019 to 2020, she will serve as President of the Malaysian Society of Pharmacology and Physiology. Her study focused on the effects of steroids on macrophage inflammatory protein 2 gamma in the endometrium. She was made a life member of Lucy Cavendish College, Cambridge, and a Fellow of the Cambridge Commonwealth Trust. Her scientific interests include colorectal cancer, inflammatory bowel illness, colitis-associated cancer, and gynecological diseases, with an emphasis on genetics, epigenomics, transcriptomics, and metagenomics.

Reproductive Biology | Molecular Biology | GUT related diseases

Michael Retsky (University of Chicago, Ph.D. in Physics) switched careers thirty years ago to work on cancer research. He works at the Harvard T.H. Chan School of Public Health and the Boston-based Angiogenesis Foundation. He is also a member of the University College London faculty. He spent 12 years on Judah Folkman's Harvard Medical School staff. Retsky is the Editor-in-Chief of the Journal of Bioequivalence and Bioavailability and the Editor-in-Chief of a Nature/Springer book on breast cancer due out in 2017. He is a co-founder of the Colon Cancer Alliance and serves on its Board of Directors. He has published over 60 publications in the fields of physics and cancer. In 1994, he was diagnosed with stage IIIc colon cancer. He chose against utilising standard maximum tolerated chemotherapy based on his earlier study on tumour growth and therapy. Instead, he employed a low-dose, long-term therapy with the standard colon cancer medicine 5-fluorouracil, which he delivered daily with a portable infusion pump. The therapy was non-toxic and appears to have succeeded because he has not relapsed and the risk of relapse has passed.

Breast Cancer